Skip to main content

Quane Alessandrea C.'s Form 4/A amendment

Amended

Oscar Health, Inc. (OSCR) · filed Aug 15, 2023

Accession no.
0001562180-23-006350
Filed
Aug 15, 2023
Trade date
Jun 2, 2023
Filing delay
74 days
Rule 10b5-1 plan
Checked
Original filed
Jun 5, 2023

This filing lists 1 non-derivative transaction. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $116.7K. It was filed 74 days after the trade.

This amendment restates part of 0001562180-23-004779 (filed Jun 5, 2023). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Quane Alessandrea C.CIK 0001667819Officer (EVP, Chief Insurance Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2023Class A Common StockSSaleDisposed−16,324$7.15F2−$116,716.6213,398Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001562180-23-004779 (filed Jun 5, 2023).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001562180-23-004779
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2023Class A Common StockMOption exerciseAcquired+7,015–F1–195,343Direct
Jun 1, 2023Class A Common StockMOption exerciseAcquired+34,379–F1–229,722Direct

Derivative securities (Table II)

Derivative transactions carried over from 0001562180-23-004779
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 1, 2023Class A Common StockMOption exerciseDisposed−7,015$0.00$063,142Direct
Jun 1, 2023Class A Common StockMOption exerciseDisposed−34,379$0.00$0515,694Direct

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F1

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Referenced by the price of 2 transactions in Table I.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F2

On June 5, 2023, the Reporting Person filed a Form 4 that inadvertently reported an incorrect price in Column 4, which was mischaracterized as a weighted average price. The price for this transaction is corrected in Column 4 of this amendment.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)